CTRI/2013/05/003703
Not Yet Recruiting
Phase 2
comparison of concurrent chemoradiation with weekly versus 3 weekly cisplatin in locally advanced head and neck squamous cell carcinoma
Regional Cancer CentreTrivandrum0 sites100 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Regional Cancer CentreTrivandrum
- Enrollment
- 100
- Status
- Not Yet Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)ECOG performance status 0 and 1
- •2\)SCC of oral cavity,oropharynx,hypopharynx and larynx
Exclusion Criteria
- •1\)patients with cartilage and bone involvement
- •2\)patients with distant metastasis
- •3\)age \>70years
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 3
A comparison of concurrent chemo-radiotherapy plus hyperthermia versus concurrent chemo-radiotherapy in locally advanced cervical cancer patients: A randomized controlled trial-This study aim to compare concurrent chemoradiotherapy and concurrent chemoradiotherapy plus hyperthermia in locally advanced cervical cancer in term of treatment response rate.Deep regional hyperthermiaThermotron-RF8radiation therapychemotherapyTCTR20180711002Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy90
Completed
Phase 1
A phase I/II study of concurrent chemoradiation with irinotecan hydrochloride(CPT-11) and cisplatin(CDDP) for uterine cervical cancer. (KCOG 0328)terine cervical cancerJPRN-C000000239Kansai Clinical Oncology Group (KCOG)18
Not Yet Recruiting
Phase 2
Prospective Study of Concurrent Chemoradiotherapy with S-1 and hypofractionated radiotherapy for outpatients with early glottic squamous cell carcinomasJPRN-UMIN000023416agoya University Graduate School of Medicine, Department of Radiology40
Completed
N/A
Efficacy and toxicity of concomitant chemoradiation with weekly gemcitabine/cisplatin in comparison with weekly cisplatin in cervical cancer: a phase II, randomised trialCervical cancer (FIGO stage IB, II , III, IVA)CancerCervical cancerISRCTN29976507Shaheed Beheshti University of Medical Science (SBMU) (Iran)80
Completed
Phase 2
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canalsquamous cell carcinoma of the anal canalJPRN-UMIN000012184Japanese Radiation Oncology Study Group40